Keeping you updated on the latest Medicare and Part D news

FDA Supports New Regulation of Narcotic Painkillers

Leave a comment

The FDA recommended today several measures that change access to commonly used narcotic painkillers, including reducing the number of refills per prescription and reclassifying painkillers with hydrocodone as “Schedule II” drugs. 

The FDA had previously rejected recommendations for tighter controls on narcotic painkillers, citing potential hardships and costs for patients. The DEA has long advocated controls to reduce prescription drug abuse, especially as painkiller overdose deaths are reaching all time highs.



Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s